Request for Covid-19 Impact Assessment of this Report
The United States Biological Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Biological Drugs market, reaching US$ million by the year 2028. As for the Europe Biological Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Biological Drugs players cover Bristol-Myers Squibb, Eli Lilly, Takeda, and Pfizer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Biological Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Therapeutic Protein
Monoclonal Antibody
Vaccine
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Ambulatory Surgical Centers
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Bristol-Myers Squibb
Eli Lilly
Takeda
Pfizer
Amgen
F. Hoffmann-La Roche
Johnson & Johnson
Merck
Abbott Laboratories
Baxter
Novartis
Biogen
GlaxoSmithKline
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biological Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Biological Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Biological Drugs by Country/Region, 2017, 2022 & 2028
2.2 Biological Drugs Segment by Type
2.2.1 Therapeutic Protein
2.2.2 Monoclonal Antibody
2.2.3 Vaccine
2.2.4 Others
2.3 Biological Drugs Sales by Type
2.3.1 Global Biological Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Biological Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Biological Drugs Sale Price by Type (2017-2022)
2.4 Biological Drugs Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Surgical Centers
2.4.3 Others
2.5 Biological Drugs Sales by Application
2.5.1 Global Biological Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Biological Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Biological Drugs Sale Price by Application (2017-2022)
3 Global Biological Drugs by Company
3.1 Global Biological Drugs Breakdown Data by Company
3.1.1 Global Biological Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Biological Drugs Sales Market Share by Company (2020-2022)
3.2 Global Biological Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Biological Drugs Revenue by Company (2020-2022)
3.2.2 Global Biological Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Biological Drugs Sale Price by Company
3.4 Key Manufacturers Biological Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biological Drugs Product Location Distribution
3.4.2 Players Biological Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Biological Drugs by Geographic Region
4.1 World Historic Biological Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Biological Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Biological Drugs Annual Revenue by Geographic Region
4.2 World Historic Biological Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Biological Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Biological Drugs Annual Revenue by Country/Region
4.3 Americas Biological Drugs Sales Growth
4.4 APAC Biological Drugs Sales Growth
4.5 Europe Biological Drugs Sales Growth
4.6 Middle East & Africa Biological Drugs Sales Growth
5 Americas
5.1 Americas Biological Drugs Sales by Country
5.1.1 Americas Biological Drugs Sales by Country (2017-2022)
5.1.2 Americas Biological Drugs Revenue by Country (2017-2022)
5.2 Americas Biological Drugs Sales by Type
5.3 Americas Biological Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biological Drugs Sales by Region
6.1.1 APAC Biological Drugs Sales by Region (2017-2022)
6.1.2 APAC Biological Drugs Revenue by Region (2017-2022)
6.2 APAC Biological Drugs Sales by Type
6.3 APAC Biological Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Biological Drugs by Country
7.1.1 Europe Biological Drugs Sales by Country (2017-2022)
7.1.2 Europe Biological Drugs Revenue by Country (2017-2022)
7.2 Europe Biological Drugs Sales by Type
7.3 Europe Biological Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biological Drugs by Country
8.1.1 Middle East & Africa Biological Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Biological Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Biological Drugs Sales by Type
8.3 Middle East & Africa Biological Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biological Drugs
10.3 Manufacturing Process Analysis of Biological Drugs
10.4 Industry Chain Structure of Biological Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biological Drugs Distributors
11.3 Biological Drugs Customer
12 World Forecast Review for Biological Drugs by Geographic Region
12.1 Global Biological Drugs Market Size Forecast by Region
12.1.1 Global Biological Drugs Forecast by Region (2023-2028)
12.1.2 Global Biological Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Biological Drugs Forecast by Type
12.7 Global Biological Drugs Forecast by Application
13 Key Players Analysis
13.1 Bristol-Myers Squibb
13.1.1 Bristol-Myers Squibb Company Information
13.1.2 Bristol-Myers Squibb Biological Drugs Product Offered
13.1.3 Bristol-Myers Squibb Biological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bristol-Myers Squibb Main Business Overview
13.1.5 Bristol-Myers Squibb Latest Developments
13.2 Eli Lilly
13.2.1 Eli Lilly Company Information
13.2.2 Eli Lilly Biological Drugs Product Offered
13.2.3 Eli Lilly Biological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Eli Lilly Main Business Overview
13.2.5 Eli Lilly Latest Developments
13.3 Takeda
13.3.1 Takeda Company Information
13.3.2 Takeda Biological Drugs Product Offered
13.3.3 Takeda Biological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Takeda Main Business Overview
13.3.5 Takeda Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Biological Drugs Product Offered
13.4.3 Pfizer Biological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Amgen
13.5.1 Amgen Company Information
13.5.2 Amgen Biological Drugs Product Offered
13.5.3 Amgen Biological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Amgen Main Business Overview
13.5.5 Amgen Latest Developments
13.6 F. Hoffmann-La Roche
13.6.1 F. Hoffmann-La Roche Company Information
13.6.2 F. Hoffmann-La Roche Biological Drugs Product Offered
13.6.3 F. Hoffmann-La Roche Biological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 F. Hoffmann-La Roche Main Business Overview
13.6.5 F. Hoffmann-La Roche Latest Developments
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Information
13.7.2 Johnson & Johnson Biological Drugs Product Offered
13.7.3 Johnson & Johnson Biological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Johnson & Johnson Main Business Overview
13.7.5 Johnson & Johnson Latest Developments
13.8 Merck
13.8.1 Merck Company Information
13.8.2 Merck Biological Drugs Product Offered
13.8.3 Merck Biological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Merck Main Business Overview
13.8.5 Merck Latest Developments
13.9 Abbott Laboratories
13.9.1 Abbott Laboratories Company Information
13.9.2 Abbott Laboratories Biological Drugs Product Offered
13.9.3 Abbott Laboratories Biological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Abbott Laboratories Main Business Overview
13.9.5 Abbott Laboratories Latest Developments
13.10 Baxter
13.10.1 Baxter Company Information
13.10.2 Baxter Biological Drugs Product Offered
13.10.3 Baxter Biological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Baxter Main Business Overview
13.10.5 Baxter Latest Developments
13.11 Novartis
13.11.1 Novartis Company Information
13.11.2 Novartis Biological Drugs Product Offered
13.11.3 Novartis Biological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Novartis Main Business Overview
13.11.5 Novartis Latest Developments
13.12 Biogen
13.12.1 Biogen Company Information
13.12.2 Biogen Biological Drugs Product Offered
13.12.3 Biogen Biological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Biogen Main Business Overview
13.12.5 Biogen Latest Developments
13.13 GlaxoSmithKline
13.13.1 GlaxoSmithKline Company Information
13.13.2 GlaxoSmithKline Biological Drugs Product Offered
13.13.3 GlaxoSmithKline Biological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 GlaxoSmithKline Main Business Overview
13.13.5 GlaxoSmithKline Latest Developments
14 Research Findings and Conclusion
Table 1. Biological Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Biological Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Therapeutic Protein
Table 4. Major Players of Monoclonal Antibody
Table 5. Major Players of Vaccine
Table 6. Major Players of Others
Table 7. Global Biological Drugs Sales by Type (2017-2022) & (K MT)
Table 8. Global Biological Drugs Sales Market Share by Type (2017-2022)
Table 9. Global Biological Drugs Revenue by Type (2017-2022) & ($ million)
Table 10. Global Biological Drugs Revenue Market Share by Type (2017-2022)
Table 11. Global Biological Drugs Sale Price by Type (2017-2022) & (USD/MT)
Table 12. Global Biological Drugs Sales by Application (2017-2022) & (K MT)
Table 13. Global Biological Drugs Sales Market Share by Application (2017-2022)
Table 14. Global Biological Drugs Revenue by Application (2017-2022)
Table 15. Global Biological Drugs Revenue Market Share by Application (2017-2022)
Table 16. Global Biological Drugs Sale Price by Application (2017-2022) & (USD/MT)
Table 17. Global Biological Drugs Sales by Company (2020-2022) & (K MT)
Table 18. Global Biological Drugs Sales Market Share by Company (2020-2022)
Table 19. Global Biological Drugs Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Biological Drugs Revenue Market Share by Company (2020-2022)
Table 21. Global Biological Drugs Sale Price by Company (2020-2022) & (USD/MT)
Table 22. Key Manufacturers Biological Drugs Producing Area Distribution and Sales Area
Table 23. Players Biological Drugs Products Offered
Table 24. Biological Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Biological Drugs Sales by Geographic Region (2017-2022) & (K MT)
Table 28. Global Biological Drugs Sales Market Share Geographic Region (2017-2022)
Table 29. Global Biological Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Biological Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Biological Drugs Sales by Country/Region (2017-2022) & (K MT)
Table 32. Global Biological Drugs Sales Market Share by Country/Region (2017-2022)
Table 33. Global Biological Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Biological Drugs Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Biological Drugs Sales by Country (2017-2022) & (K MT)
Table 36. Americas Biological Drugs Sales Market Share by Country (2017-2022)
Table 37. Americas Biological Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Biological Drugs Revenue Market Share by Country (2017-2022)
Table 39. Americas Biological Drugs Sales by Type (2017-2022) & (K MT)
Table 40. Americas Biological Drugs Sales Market Share by Type (2017-2022)
Table 41. Americas Biological Drugs Sales by Application (2017-2022) & (K MT)
Table 42. Americas Biological Drugs Sales Market Share by Application (2017-2022)
Table 43. APAC Biological Drugs Sales by Region (2017-2022) & (K MT)
Table 44. APAC Biological Drugs Sales Market Share by Region (2017-2022)
Table 45. APAC Biological Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Biological Drugs Revenue Market Share by Region (2017-2022)
Table 47. APAC Biological Drugs Sales by Type (2017-2022) & (K MT)
Table 48. APAC Biological Drugs Sales Market Share by Type (2017-2022)
Table 49. APAC Biological Drugs Sales by Application (2017-2022) & (K MT)
Table 50. APAC Biological Drugs Sales Market Share by Application (2017-2022)
Table 51. Europe Biological Drugs Sales by Country (2017-2022) & (K MT)
Table 52. Europe Biological Drugs Sales Market Share by Country (2017-2022)
Table 53. Europe Biological Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Biological Drugs Revenue Market Share by Country (2017-2022)
Table 55. Europe Biological Drugs Sales by Type (2017-2022) & (K MT)
Table 56. Europe Biological Drugs Sales Market Share by Type (2017-2022)
Table 57. Europe Biological Drugs Sales by Application (2017-2022) & (K MT)
Table 58. Europe Biological Drugs Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Biological Drugs Sales by Country (2017-2022) & (K MT)
Table 60. Middle East & Africa Biological Drugs Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Biological Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Biological Drugs Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Biological Drugs Sales by Type (2017-2022) & (K MT)
Table 64. Middle East & Africa Biological Drugs Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Biological Drugs Sales by Application (2017-2022) & (K MT)
Table 66. Middle East & Africa Biological Drugs Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Biological Drugs
Table 68. Key Market Challenges & Risks of Biological Drugs
Table 69. Key Industry Trends of Biological Drugs
Table 70. Biological Drugs Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Biological Drugs Distributors List
Table 73. Biological Drugs Customer List
Table 74. Global Biological Drugs Sales Forecast by Region (2023-2028) & (K MT)
Table 75. Global Biological Drugs Sales Market Forecast by Region
Table 76. Global Biological Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Biological Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Biological Drugs Sales Forecast by Country (2023-2028) & (K MT)
Table 79. Americas Biological Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Biological Drugs Sales Forecast by Region (2023-2028) & (K MT)
Table 81. APAC Biological Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Biological Drugs Sales Forecast by Country (2023-2028) & (K MT)
Table 83. Europe Biological Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Biological Drugs Sales Forecast by Country (2023-2028) & (K MT)
Table 85. Middle East & Africa Biological Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Biological Drugs Sales Forecast by Type (2023-2028) & (K MT)
Table 87. Global Biological Drugs Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Biological Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Biological Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Biological Drugs Sales Forecast by Application (2023-2028) & (K MT)
Table 91. Global Biological Drugs Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Biological Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Biological Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 94. Bristol-Myers Squibb Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Bristol-Myers Squibb Biological Drugs Product Offered
Table 96. Bristol-Myers Squibb Biological Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 97. Bristol-Myers Squibb Main Business
Table 98. Bristol-Myers Squibb Latest Developments
Table 99. Eli Lilly Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Eli Lilly Biological Drugs Product Offered
Table 101. Eli Lilly Biological Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 102. Eli Lilly Main Business
Table 103. Eli Lilly Latest Developments
Table 104. Takeda Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Takeda Biological Drugs Product Offered
Table 106. Takeda Biological Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 107. Takeda Main Business
Table 108. Takeda Latest Developments
Table 109. Pfizer Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Pfizer Biological Drugs Product Offered
Table 111. Pfizer Biological Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 112. Pfizer Main Business
Table 113. Pfizer Latest Developments
Table 114. Amgen Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Amgen Biological Drugs Product Offered
Table 116. Amgen Biological Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 117. Amgen Main Business
Table 118. Amgen Latest Developments
Table 119. F. Hoffmann-La Roche Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. F. Hoffmann-La Roche Biological Drugs Product Offered
Table 121. F. Hoffmann-La Roche Biological Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 122. F. Hoffmann-La Roche Main Business
Table 123. F. Hoffmann-La Roche Latest Developments
Table 124. Johnson & Johnson Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. Johnson & Johnson Biological Drugs Product Offered
Table 126. Johnson & Johnson Biological Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 127. Johnson & Johnson Main Business
Table 128. Johnson & Johnson Latest Developments
Table 129. Merck Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 130. Merck Biological Drugs Product Offered
Table 131. Merck Biological Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 132. Merck Main Business
Table 133. Merck Latest Developments
Table 134. Abbott Laboratories Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 135. Abbott Laboratories Biological Drugs Product Offered
Table 136. Abbott Laboratories Biological Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 137. Abbott Laboratories Main Business
Table 138. Abbott Laboratories Latest Developments
Table 139. Baxter Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 140. Baxter Biological Drugs Product Offered
Table 141. Baxter Biological Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 142. Baxter Main Business
Table 143. Baxter Latest Developments
Table 144. Novartis Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 145. Novartis Biological Drugs Product Offered
Table 146. Novartis Biological Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 147. Novartis Main Business
Table 148. Novartis Latest Developments
Table 149. Biogen Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 150. Biogen Biological Drugs Product Offered
Table 151. Biogen Biological Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 152. Biogen Main Business
Table 153. Biogen Latest Developments
Table 154. GlaxoSmithKline Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 155. GlaxoSmithKline Biological Drugs Product Offered
Table 156. GlaxoSmithKline Biological Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 157. GlaxoSmithKline Main Business
Table 158. GlaxoSmithKline Latest Developments
List of Figures
Figure 1. Picture of Biological Drugs
Figure 2. Biological Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biological Drugs Sales Growth Rate 2017-2028 (K MT)
Figure 7. Global Biological Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Biological Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Therapeutic Protein
Figure 10. Product Picture of Monoclonal Antibody
Figure 11. Product Picture of Vaccine
Figure 12. Product Picture of Others
Figure 13. Global Biological Drugs Sales Market Share by Type in 2021
Figure 14. Global Biological Drugs Revenue Market Share by Type (2017-2022)
Figure 15. Biological Drugs Consumed in Hospitals
Figure 16. Global Biological Drugs Market: Hospitals (2017-2022) & (K MT)
Figure 17. Biological Drugs Consumed in Ambulatory Surgical Centers
Figure 18. Global Biological Drugs Market: Ambulatory Surgical Centers (2017-2022) & (K MT)
Figure 19. Biological Drugs Consumed in Others
Figure 20. Global Biological Drugs Market: Others (2017-2022) & (K MT)
Figure 21. Global Biological Drugs Sales Market Share by Application (2017-2022)
Figure 22. Global Biological Drugs Revenue Market Share by Application in 2021
Figure 23. Biological Drugs Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Biological Drugs Revenue Market Share by Company in 2021
Figure 25. Global Biological Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Biological Drugs Revenue Market Share by Geographic Region in 2021
Figure 27. Global Biological Drugs Sales Market Share by Region (2017-2022)
Figure 28. Global Biological Drugs Revenue Market Share by Country/Region in 2021
Figure 29. Americas Biological Drugs Sales 2017-2022 (K MT)
Figure 30. Americas Biological Drugs Revenue 2017-2022 ($ Millions)
Figure 31. APAC Biological Drugs Sales 2017-2022 (K MT)
Figure 32. APAC Biological Drugs Revenue 2017-2022 ($ Millions)
Figure 33. Europe Biological Drugs Sales 2017-2022 (K MT)
Figure 34. Europe Biological Drugs Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Biological Drugs Sales 2017-2022 (K MT)
Figure 36. Middle East & Africa Biological Drugs Revenue 2017-2022 ($ Millions)
Figure 37. Americas Biological Drugs Sales Market Share by Country in 2021
Figure 38. Americas Biological Drugs Revenue Market Share by Country in 2021
Figure 39. United States Biological Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Biological Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Biological Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Biological Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Biological Drugs Sales Market Share by Region in 2021
Figure 44. APAC Biological Drugs Revenue Market Share by Regions in 2021
Figure 45. China Biological Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Biological Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Biological Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Biological Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Biological Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Biological Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Biological Drugs Sales Market Share by Country in 2021
Figure 52. Europe Biological Drugs Revenue Market Share by Country in 2021
Figure 53. Germany Biological Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Biological Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Biological Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Biological Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Biological Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Biological Drugs Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Biological Drugs Revenue Market Share by Country in 2021
Figure 60. Egypt Biological Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Biological Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Biological Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Biological Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Biological Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Biological Drugs in 2021
Figure 66. Manufacturing Process Analysis of Biological Drugs
Figure 67. Industry Chain Structure of Biological Drugs
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...